Sanofi stock: JPMorgan keeps EUR 85 target in pre-market trading
Published on 10/22/2026 at 08:55 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWSAnalyst view and next date
- JPMorgan maintained its neutral rating on Sanofi and kept its price target at EUR 85.00 on October 21, 2026.
- Sanofi’s third-quarter 2026 results webcast is scheduled for October 30, 2026.
- Sanofi stock trades pre-market at EUR 73.08 at 8:53 a.m. CEST at Lang & Schwarz on October 22, 2026.
On October 21, 2026, JPMorgan maintained its neutral rating on Sanofi and kept its price target at EUR 85.00, according to Zonebourse. Sanofi stock was at EUR 73.08 at Lang & Schwarz at 8:53 a.m. CEST on October 22, 2026.
JPMorgan maintains neutral view
The report said JPMorgan continued to rate the shares neutral and retained the EUR 85.00 target. The analyst action was published before the pre-market session on October 22, 2026, and is the latest company-specific item in the reviewed coverage.
Ahead of the Xetra open
The pre-market indication is being monitored ahead of the Xetra open. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Sanofi stock.
Business and upcoming date
Sanofi is a global pharmaceutical company that develops and supplies medicines and vaccines, according to its investor-relations materials. The company’s third-quarter 2026 results will be presented during a webcast on October 30, 2026, from 1:30 p.m. to 2:30 p.m. CET, followed by a question-and-answer session, Sanofi said on its investor page.
Market context: Market report CAC 40.
